Tocilizumab is associated with reduction of the risk of ICU admission and mortality in patients with SARS-CoV-2 infection - E. Moreno-García, Rico, L. Albiach, D. Agüero, J. Ambrosioni, M. Bodro, C. Cardozo, M. Chumbita, L. de la Mora, N. García-Pouton, C. Garcia-Vidal, A. González-Cordón, M. Hernández-Meneses, A. Inciarte, M. Laguno - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

Links

ORCID

Tools

Export citation

Search in Google Scholar

Tocilizumab is associated with reduction of the risk of ICU admission and mortality in patients with SARS-CoV-2 infection

Published in 2020 by E. Moreno-García, Rico, L. Albiach, D. Agüero, J. Ambrosioni, M. Bodro, C. Cardozo, M. Chumbita, L. de la Mora, N. García-Pouton, C. Garcia-Vidal, A. González-Cordón, M. Hernández-Meneses, A. Inciarte, M. Laguno and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle

Preprint: policy unknown

Upload

Question mark in circle

Postprint: policy unknown

Upload

Question mark in circle

Published version: policy unknown

Upload